Evidence map›Paper›PMID 32458208›Full record

ArticleInternational urology and nephrology2020

The impact of gender difference on the relationship between serum high-density lipoprotein level and cardiovascular events in incident dialysis patients: a multicenter prospective cohort study.

Miho Tatematsu, Daijo Inaguma, Takumi Yamada, Izumi Sakamoto, Masako Sakakibara

Abstract readComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miho TatematsuDepartment of Nephrology, Nagoya Memorial Hospital, Nagoya City, Aichi Prefecture, Japan.
Daijo InagumaDepartment of Nephrology, Fujita Health University School of Medicine, Dengakugakubo 1-98, Kutsukake, Toyoake City, Aichi Prefecture, 470-1192, Japan. daijo@fujita-hu.ac.jp.ORCID http://orcid.org/0000-0002-3977-5933
Takumi YamadaDepartment of Nephrology, Nagoya Memorial Hospital, Nagoya City, Aichi Prefecture, Japan.
Izumi SakamotoSakamoto Internal Medicine and Nephrology Clinic, Nagoya City, Aichi Prefecture, Japan.
Masako SakakibaraDepartment of Nephrology, Nagoya Memorial Hospital, Nagoya City, Aichi Prefecture, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to clarify the relationship between serum high-density lipoprotein cholesterol (HDL-C) level and incidence of CV events. Moreover, the relationship stratified by gender was evaluated.

methodsThe study database was derived from a multicenter, prospective, cohort study that included 1520 incident dialysis patients in Aichi Prefecture, Japan. Baseline was defined as the time of dialysis initiation and outcome as incidence of CV event. The enrolled patients were first classified into four quartile groups (Q1, Q2, Q3, and Q4; Q1 was the lowest serum HDL-C) based on serum HDL-C level. A multivariate Cox proportional hazards analysis was conducted using the stepwise regression method to determine factors associated with outcomes and was performed in each gender.

resultsThe log-rank test revealed significant differences in the incidence of CV events between not only the four groups (p = 0.003) but also the male and female patients (HR, 0.74; 95% CI, 0.59-0.92; p < 0.001). Stepwise regression analysis indicated that higher serum HDL-C level was significantly associated with lower incidence of CV events (HR, 0.88; 95% CI, 0.82-0.95; p = 0.001). The association between serum HDL-C and incidence of CV events could be clarified in only female patients (male patients; HR, 0.92; 95% CI, 0.84-1.01; p = 0.067 and female patients; HR, 0.81; 95% CI, 0.72-0.92; p = 0.001).

conclusionsHDL-C level at the initiation of dialysis was associated with the incidence of CV events. Moreover, the association was prominent in female patients.

trial registrationThe trial registration number of the study is UMIN 7096, registered on January 18, 2012.

Indexed as

Renal DialysisAgedAged, 80 and overCardiovascular DiseasesCholesterol, HDLCohort StudiesFemaleHumansIncidenceMaleMiddle AgedProspective StudiesRenal Insufficiency, ChronicSex FactorsCholesterol, HDLCardiovascular eventDialysis initiationGender differenceHigh-density lipoprotein cholesterolMulticenter prospective cohort study

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.